Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: Results From a Phase III Open‐Label Study

OBJECTIVE: To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (SC) abatacept treatment over 24 months in patients with polyarticular‐course juvenile idiopathic arthritis (JIA). METHODS: In this phase III, open‐label, international, multicenter, single‐arm study, patients...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arthritis Rheumatol
Main Authors: Brunner, Hermine I., Tzaribachev, Nikolay, Vega‐Cornejo, Gabriel, Louw, Ingrid, Berman, Alberto, Calvo Penadés, Inmaculada, Antón, Jordi, Ávila‐Zapata, Francisco, Cuttica, Rubén, Horneff, Gerd, Foeldvari, Ivan, Keltsev, Vladimir, Kingsbury, Daniel J., Viola, Diego Oscar, Joos, Rik, Lauwerys, Bernard, Paz Gastañaga, Maria Eliana, Rama, Maria Elena, Wouters, Carine, Bohnsack, John, Breedt, Johannes, Fischbach, Michel, Lutz, Thomas, Minden, Kirsten, Miraval, Tatiana, Ally, Mahmood M. T. M., Rubio‐Pérez, Nadina, Solau Gervais, Elisabeth, van Zyl, Riana, Li, Xiaohui, Nys, Marleen, Wong, Robert, Banerjee, Subhashis, Lovell, Daniel J., Martini, Alberto, Ruperto, Nicolino
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Pediatric Rheumatology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032847/
https://ncbi.nlm.nih.gov/pubmed/29481737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40466
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares